ESPR — Esperion Therapeutics Inc

Ownership history in Diametric Capital, LP  ·  10 quarters on record

This page tracks every 13F SEC filing in which Diametric Capital, LP reported a position in Esperion Therapeutics Inc (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.9% (2024 Q2)
Avg. % of fund
0.39%
First filed
2021 Q1
Last filed
2025 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 169,006 -67,139 -28.4% 0.17% $625K $3.70
2025 Q3 REDUCED 236,145 -442,679 -65.2% 0.23% $626K $2.65
2025 Q2 ADDED 678,824 +248,648 +57.8% 0.36% $668K $0.98
2025 Q1 ADDED 430,176 +76,166 +21.5% 0.74% $619K $1.44
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ESPR price (monthly, adj. close)

Other funds also holding ESPR

As of 2025 Q4 — sorted by position size

AIGH Capital Management LLC 3Y 3.58% Velan Capital Investment Management LP 3Y 2.6% PenderFund Capital Management Ltd. 3Y 7Y 2.56% Two Seas Capital LP 3Y 0.91% Eversept Partners, LP 3Y 7Y 0.72% nVerses Capital, LLC 0.56% ORBIMED ADVISORS LLC 3Y 7Y 0.45% Summit Wealth Group, LLC 3Y 0.29% WASATCH ADVISORS LP 3Y 7Y 0.21% Virtus Investment Advisers, LLC 3Y 7Y 0.18%
← Back to Diametric Capital, LP Holdings